Aries FilterWorks HPL-RO Installation And Service Manual - Page 2

Browse online or download pdf Installation And Service Manual for Water Filtration Systems Aries FilterWorks HPL-RO. Aries FilterWorks HPL-RO 7 pages. Reverse osmosis system

Print Page

Introduction:

Read this entire service guide before beginning installation. The Aries HPL-RO system has been

designed for quick and simple installation and maintenance. By carefully reading this instruction

manual and following the operational guidelines, successful installation and reliable operation

will be insured.

System Description:

The Aries HPL-RO system is a 4-stage filtration system designed to remove more than 93% of

dissolved solids of a potable water supply. The purpose of each stage is described below:

Stage (1) – Sediment Filter: 5.0 micron filter designed to remove suspended particles like silt,

sand, or clay.

Stage (2) – Granular Activated Carbon: 20 x 50 mesh carbon designed to remove chlorine and

organics.

Stage (3) – Membrane Pre Filter: 1.0 micron filter designed to trap carbon fines and other

smaller suspended particles.

Stage (4) – Thin Film Composite Membrane: Polyamide reverse osmosis membrane that uses a

cross flow design to produce two product streams: permeate and concentrate. Permeate is the

purified stream that has >93% of dissolved solids removed. Concentrate is the removed salt

content that is sent to drain.

Conditions for Operation - Thin Film Composite Membrane:

Source Water Supply

System Pressure – 2.1 – 6.9 bar (30-100 psi)

Temperature – 4 - 38 ºC (40 - 100 ºF)

ph Range – 3.0 to 11.0

Maximum Supply TDS level – 2000 mg/L

Turbidity - < 1.0 net turbidity (NTU)

Chemical Parameter

Hardness - < 350 mg/L (<20 gpg)

Iron (Fe) - < 0.1 mg/L

Manganese - < 0.05 mg/L

Hydrogen Sulfide (H

) – 0.00 mg/L

Chlorine (Cl

CAUTION: DO NOT USE THIS SYSTEM WHERE THE WATER IS MICROBIOLOGICALLY UNSAFE OR

OF UNKNOWN QUALITY. THIS SYSTEM IS FOR USE ON POTABLE WATER ONLY. SOURCE WATER

EXCEEDING CHEMICAL PARAMETERS REQUIRES PRETREATMENT.

M-0221201113

Revision 4

S) – 0.00 mg/L

Page 2 of 7